Dr. Kris M. Mahadeo
Claim this profileM D Anderson Cancer Center
Area of expertise
Sickle Cell Disease
Kris M. Mahadeo has run 2 trials for Sickle Cell Disease. Some of their research focus areas include:
Bone Marrow Transplant
Kris M. Mahadeo has run 2 trials for Bone Marrow Transplant. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
University Of Texas MD Anderson Cancer Center
Clinical Trials Kris M. Mahadeo is currently running
Non-TBI Conditioning
for HCT in Acute Lymphoblastic Leukemia
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT). Patients diagnosed with B-ALL who are candidates for HCT will be screened by NGS-MRD on a test of bone marrow done before the HCT. Subjects who are pre-HCT NGS-MRD negative will be eligible to receive a non-TBI conditioning regimen as part of the treatment cohort of the study. Subjects who are pre-HCT NGS-MRD positive will be treated as per treating center standard and will be followed in an observational cohort (HCT center standard of care).
Recruiting
1 award
Phase 2
Tabelecleucel
for EBV Associated Diseases
This trial tests tabelecleucel, a treatment using special immune cells, in patients with certain diseases related to the Epstein-Barr virus (EBV) who can't use or don't respond to standard treatments. It works by enhancing the immune system's ability to attack virus-infected cells. Tabelecleucel is being tested for recurring or hard-to-treat EBV-related diseases.
Recruiting
1 award
Phase 2
2 criteria
More about Kris M. Mahadeo
Clinical Trial Related
5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Kris M. Mahadeo has experience with
- Fludarabine Phosphate
- Tacrolimus
- Mycophenolate Mofetil
- Fludarabine
- Cyclophosphamide
- Thiotepa
Breakdown of trials Kris M. Mahadeo has run
Sickle Cell Disease
Bone Marrow Transplant
Solid Tumors
Neuroblastoma
Peripheral Nerve Sheath Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kris M. Mahadeo specialize in?
Kris M. Mahadeo focuses on Sickle Cell Disease and Bone Marrow Transplant. In particular, much of their work with Sickle Cell Disease has involved HLA-A positive patients, or patients who are RB1 negative.
Is Kris M. Mahadeo currently recruiting for clinical trials?
Yes, Kris M. Mahadeo is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Kris M. Mahadeo has studied deeply?
Yes, Kris M. Mahadeo has studied treatments such as Fludarabine Phosphate, Tacrolimus, Mycophenolate Mofetil.
What is the best way to schedule an appointment with Kris M. Mahadeo?
Apply for one of the trials that Kris M. Mahadeo is conducting.
What is the office address of Kris M. Mahadeo?
The office of Kris M. Mahadeo is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.